Antimicrobial resistance (AR), especially among bacterial pathogens, has escalated to the level of a significant public health threat and presents formidable challenges to healthcare providers. In many instances, no antimicrobial agents are available for effective therapy. For the past 1-2 decades much attention has been focused on Gram-positive organism, especially methicillin-resistant Staphylococcus aureus (MRSA) and vancomycin-resistant enterococci (VRE). In more recent past the emergence of a variety of resistance mechanisms among Gram-negative pathogens have emerged and are recognized. International concerns about drug resistance among strains of tuberculosis and parasites are also considered. These pathogens are recognized in human and animal healthcare settings, communities, the environment, food sources, and agriculture and animal production. The diversity of resistance type and their wide spread presence requires a multi-disciplinary approach to their study.
The Antimicrobial Resistance Interest Group is a multi-disciplinary group of investigators and clinicians whose goal is to investigate the development, acquisition, and transmission of AR pathogens. Investigation by this group occurs in the basic science laboratory, within human and animal clinical settings, at the human-animal interface, in food production, and in the environment. In 2010 CMIB established this group of investigators who meet regularly to exchange ideas, discuss scientific and programmatic themes, promote collaborate on research projects, and work towards enhanced funding to support the activities of the group.
Dr. Kurt B. Stevenson, MD, MPH
Professor of Medicine and Epidemiology
Division of Infectious Diseases
Department of Internal Medicine
The Ohio State University College of Medicine
The Division of Epidemiology
The Ohio State University College of Public Health
N1122 Doan Hall
410 West 10th Avenue
Columbus, OH 43210
Office (614) 293-5666
FAX (614) 293-4556